Epitomee Medical Ltd (TLV:EPIT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 837.40
-17.40 (-2.04%)
Apr 28, 2026, 5:24 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 251.95 million as of April 28, 2026. Its market cap has decreased by -3.75% in one year.
Market Cap
251.95M
Enterprise Value
226.18M
Revenue
679.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
837.40
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 251.95M, a decrease of -79.10%. That is a compound annual growth rate of -30.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 257.18M | 41.14% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 106.60B |
| Danel (Adir Yeoshua) | 2.87B |
| Amal Holdings A.D. | 2.40B |
| BrainsWay | 1.99B |
| Ilex Medical | 627.99M |
| Novolog (Pharm-Up 1966) | 520.58M |
| Bonus BioGroup | 456.74M |
| Geffen Residence & Renewal | 270.51M |